ArticleInternational journal of surgery case reports2026
Dermatomyositis as a paraneoplastic sign of breast cancer: a case report and literature review.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dermatomyositis (DM) is a rare autoimmune inflammatory disorder characterized by skin and muscle involvement and is well known for its association with malignancy. Clinically amyopathic dermatomyositis (ADM) is a distinct subtype that presents with characteristic cutaneous manifestations in the absence of clinically significant muscle weakness, which may delay diagnosis. ADM can occur as a paraneoplastic syndrome and warrants thorough evaluation for underlying malignancy. Case presentation: A 39-year-old Iranian premenopausal woman presented with a one-year history of a neglected right breast mass and progressive pruritic erythematous skin lesions involving the trunk and upper extremities. Physical examination revealed no muscle weakness. Imaging demonstrated a large right breast mass with bilateral axillary lymphadenopathy. Core needle biopsy confirmed grade 3 invasive ductal carcinoma (ER-positive, PR-positive, HER2-negative). Laboratory tests showed mild elevated inflammatory markers and muscle enzymes. Skin biopsy findings were consistent with dermatomyositis. Corticosteroid therapy was ineffective. A diagnosis of paraneoplastic clinically amyopathic dermatomyositis was established. Following initiation of neoadjuvant chemotherapy with doxorubicin and cyclophosphamide, cutaneous lesions resolved completely after the first treatment cycle. The patient subsequently underwent surgery and adjuvant radiotherapy, with no recurrence during follow-up. Discussion: DM may represent a paraneoplastic manifestation of breast cancer and poses diagnostic challenges, particularly in the absence of muscle involvement. Steroid resistance and rapid resolution following chemotherapy support a tumor-driven immune mechanism. Conclusion: Early recognition of paraneoplastic ADM and prompt cancer-directed therapy are essential for optimal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.